|Poll|June 23, 2021

Poll: Medical Aid in Dying

What are your thoughts on medical aid in dying?

Canada just passed a law that has opened a path to euthanasia for patients with psychiatric illness who find their conditions unbearable. In your opinion:

Should psychiatrists assist with medical aid in dying in general?

Should medical aid in dying be available to patients with psychiatric disorders?

If you have more to say on this subject, write us at PTEditor@MMHGroup.com.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

Lethal Suicide Deniers

ByAlan A. Abrams, MD, JD,Nicolas Badre, MD,Jason Compton, MD

September 22nd 2025

Self-Identified Palliative Psychiatrists Should Disclose Their Views on Psychiatric Euthanasia

ByKarandeep Sonu Gaind, MD

July 8th 2025

Death and Personal Aid in Dying (PAID)

ByH. Steven Moffic, MD

June 26th 2025

A Philosophical Spark about the Fragility of Existence: A Response to Vincenzo Di Nicola

ByClaudia Goméz Robledo

June 3rd 2025

The Therapeutic Alliance

ByJohn J. Miller, MD

May 8th 2025

Latest CME

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Poll: Medical Aid in Dying

Newsletter

Related Content

Lethal Suicide Deniers

Self-Identified Palliative Psychiatrists Should Disclose Their Views on Psychiatric Euthanasia

Death and Personal Aid in Dying (PAID)

A Philosophical Spark about the Fragility of Existence: A Response to Vincenzo Di Nicola

The Therapeutic Alliance

Latest CME

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Psychedelic PSX-001 for Generalized Anxiety Disorder: A Conversation With Lou Barbato, MD

The Concept of Mental Illness, and Why the DSM Approach Is Wrong

Antidepressants Assessed for Reducing Negative Symptoms of Schizophrenia

Favorable Profile Data On MK-2214 for Treatment of Alzheimer Disease

Psychiatry Wrapped 2025: Year in Review